Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses.
RMD Open
; 8(1)2022 05.
Article
in English
| MEDLINE | ID: covidwho-1950260
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
COVID-19
Topics:
Vaccines
Limits:
Humans
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
Rmdopen-2022-002308
Similar
MEDLINE
...
LILACS
LIS